secwatch.observer — SEC 8-K summary
======================================

Issuer:     Summit Therapeutics Inc. (SMMT)
CIK:        0001599298
Form:       8-K
Filed at:   2022-01-12T23:59:59+00:00
Accession:  0001599298-22-000011
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Summit Therapeutics VP Corporate Controller & PAO Jeffrey Maranian resigns effective Jan 21, 2022
--------------------------------------------------------------------------------

- Jeffrey Maranian resigned as VP Corporate Controller and Principal Accounting Officer effective Jan 21, 2022; personal decision, no disagreement with the company.
- Company plans to search for a successor for both VP Corporate Controller and Principal Accounting Officer positions.
- Maranian will assist with transition under a short-term consulting agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1599298/000159929822000011/0001599298-22-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1599298/000159929822000011/smmt-20220107.htm
  HTML page:      https://secwatch.observer/filing/0001599298-22-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer